Los Angeles Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $297K | Sell |
|
|||||
|
2021
Q4 | $840K | Sell |
|
|||||
|
2021
Q3 | $1.16M | Sell |
|
|||||
|
2021
Q2 | $1.48M | Buy |
|
|||||
|
2021
Q1 | $676K | Sell |
|
|||||
|
2020
Q4 | $1.25M | Buy |
|
|||||
|
2020
Q3 | $940K | Buy |
|
|||||
|
2020
Q2 | $886K | Buy |
|
|||||
|
2020
Q1 | $278K | Buy |
|
|||||
|
2019
Q4 | $77K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $374K | Sell |
|
|||||
|
2019
Q1 | $369K | Buy |
|
|||||
|
2018
Q4 | $208K | Sell |
|
|||||
|
2018
Q3 | $448K | Sell |
|
|||||
|
2018
Q2 | $611K | Buy |
|